Microbiología y Parasitología
Departamento
Columbia University Medical Center
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Columbia University Medical Center (4)
2021
-
The antimalarial efficacy and mechanism of resistance of the novel chemotype DDD01034957
Scientific Reports, Vol. 11, Núm. 1
2018
-
Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria" (Antimicrobial Agents and Chemotherapy (2018) 62:9 (e00012-18) DOI: 10.1128/AAC.00012-18)
Antimicrobial Agents and Chemotherapy
-
Uct943, a next-generation plasmodium falciparum pi4k inhibitor preclinical candidate for the treatment of malaria
Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 9
2017
-
A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance
Nature Communications, Vol. 8